1. Akoun GM, Scarna HM, Milleron BJ, Benichou MP, Herman DP (1985) Serum neuronspecific enolase. A marker for disease extent and response to therapy for small cell lung cancer. Chest 87: 39–43
2. Bergman B, Brezicka F, Engström C (1992) Clinical utility of serum assays of neuronspecific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnostic evaluation of lung cancer patients. Eur J Cancer 598–202
3. Blobel GA, Moll R, Franke WW, Vogt-Moykopf I (1984) Cytokeratins in normal and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines. Virchows Arch [B] 45: 407–429
4. Bodenmüller H, Banauch D, Ofenloch B, Jaworek D, Dessauer A (1992) Technical evaluation of a new automated tumor marker assay: The Enzymun-test CYFRA25–1. In: Klapdor R (ed) Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the nineties. Cancer of the breast-state and trends in diagnosis and therapy. Zuckschwerdt, München Bern Wien, pp 137–138
5. Body JJ, Sculier JP, Raymakers N, Paesmans H, Ravez P, Libert P, Richez M, Dabouis G, Lacroix H, Bureau G (1990) Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer. Cancer 65: 1552–1556